Yellow Fever Research Today is a free monthly online journal that collates and summarizes the latest research about Yellow Fever, including details on immunization, vaccines, symptoms, transmission.

Volume 2 (2006), Issue 2 (February)

1. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
   Virology, 345(2): 299-304. [Abstract] [Full-text]
2. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004.
   Vaccine, 24(6): 730-7. [Abstract] [Full-text]
3. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication.
   J Virol, 80(5): 2170-82. [Abstract] [Full-text]
4. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
   Vaccine, 24(9): 1421-6. [Abstract] [Full-text]
5. Immunohistochemical examination of the role of Fas ligand and lymphocytes in the pathogenesis of human liver yellow fever.
   Virus Res, 116(1): 91-7. [Abstract] [Full-text]
6. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
   J Exp Med, 203(2): 413-24. [Abstract] [Full-text]
7. Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited.
   J Virol, 80(6): 2976-86. [Abstract] [Full-text]
8. Secreted ferritin: mosquito defense against iron overload?
   Insect Biochem Mol Biol, 36(3): 177-87. [Abstract] [Full-text]

© 2005-2008 Yellow Fever Research Today. All Rights Reserved.